Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Items 501–531 of 531
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654422
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649531
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649513
Yousri, N. A., Albagha, O., & Hunt, S. C. (2023) · Figshare · doi:10.6084/m9.figshare.24104312
Smyth, L. J., Kilner, J., Nair, V., Liu, H., Brennan, E. P., Kerr, K., Sandholm, N., Cole, J. B., Dahlström, E., Syreeni, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14526393
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649510
Yousri, N. A., Albagha, O., & Hunt, S. C. (2023) · Figshare · doi:10.6084/m9.figshare.24104318
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649516
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · Figshare · doi:10.6084/m9.figshare.22649495
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654425
Burton, M. A., Garratt, E. S., Hewitt, M., Sharkh, H. Y., Antoun, E., Westbury, L. D., Dennison, E. M., Harvey, N. C., Cooper, C. C., MacIsaac, J. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633517
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654431
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24820092
Serum FTO Protein Levels in Newly Diagnosed Type 2 Diabetes Patients in Syria: A Case‒Control StudyPreprint
Shamsaldeenalsagher, H. F., & Haddad, S. I. (2026) · Research Square · doi:10.21203/rs.3.rs-8321576/v1
Nanopore Electroporation: A New Delivery Method Within the Field of Epigenetic Editing
Ekstrand, F., Ruhrmann, S., Bacos, K., Bartel, S., Jellema, P. G., Rots, M. G., Ling, C., & Prinz, C. N. (2026) · Small · doi:10.1002/smll.202513858
Self-citationImpacto de la microbiota intestinal en la patogénesis y terapéutica de la diabetes mellitus
Pelayo, L. N., Steinhardt, A. P., Trinks, J., Millán, A. L., Frechtel, G. D., Perone, M. J., & Andreone, L. (2026) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v60i1.1290
“Por ejem-plo, en los islotes pancreáticos de pacientes con la enfermedad se ha identificado una metilación di-ferencial en genes clave como KCNQ1 , TCF7L2 y FTO , los cuales están directamente implicados en la secreción de insulina y en la homeostasis de la glucosa 27 .”
Restaurer la fonction bêta pancréatique de la souris leptine déficiente par la chirurgie bariatrique
Amouyal, C. (2019) · theses.fr (ABES) · doi:10.70675/57e90c8dz951az4b06z95cdzc78f34db6015
Satheesh, G., Asokan, A. K., Vijayakumar, G., Rajavelu, A., Rao, S. N., Sivakumar, K. C., & Jaleel, A. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02064-6 · Cited by 1
“Hypomethylation of PTPRN2 , observed in participants progressing to prediabetes, is consistent with its role in vesicle trafficking and impaired insulin secretion [36, 39].”
Rizvi, A., Kansal, R., & Datta, M. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02892-2 · Cited by 1
“These alterations contribute to metabolic reprogramming, influencing genes that regulate insulin signaling, lipid metabolism, and glucose transport [7–10].”
Islet cell DNA methylation in human ageing and diabetes
Hodges, E. C., & Gu, G. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01502-2
Impact of Genetics on Endocrine Manifestations of Cystic Fibrosis
Wu, M., Bianco, M. E., & Blackman, S. M. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.05.021
Li, S., Hu, D., Mei, X., Kinkpe, L., Wang, S., Wei, J., Hou, S., ZHANG, Y., & Wang, X. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00565-26
Genetic and epigenetic landscape of type 2 diabetes mellitus
Patil, P. C., Surve, S., Kaleem, M., Kayali, A., & Bachhav, R. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00012-5
DNA methylation mechanisms and their contribution to metabolic pathophysiology
Gupta, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44591-0.00011-4
Metabolic memory: Future outlook
Gupta, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44591-0.00009-6
Timing as biology: a hypothesis on the role of epigenetic plasticity in type 2 diabetes prevention
Fasipe, B., Fasipe, A., & Laher, I. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.112107
Venkatesan, K. B., & Boopathe, D. (2026) · Human Gene · doi:10.1016/j.humgen.2026.201600
Singh, D., Talware, S. K., Mishra, S., Srivastava, P., Mukherjee, S., Pandey, A., Siddiqi, M. I., Tiwari, V., & Husain, N. (2026) · Epigenomics · doi:10.1080/17501911.2026.2730905
Zhang, W., Chen, L., Wu, H., You, X., Wu, W., Zhao, C., & Chen, Y. (2026) · Food Reviews International · doi:10.1080/87559129.2026.2736062
Mishra, P., Pramodkumar, T. A., Pradhan, B., Ghosh, U., Mishra, P. K., Dash, P., Anjana, R. M., Patra, S. K., & Mohan, V. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01926-9
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.